Good morning, good afternoon or good evening; we wish you a year with minimal symptoms and maximal function. This Blog will focus on year past and the year ahead.
Personalized Stem Cell Clinical Trial
The results of those 36 patients who underwent an adipose derived, stem cell knee intervention during 2019 and 2020 and have been sent to the FDA. The Trial involved seven centers across the country and I was responsible for 16 of the 36 patients enrolled and monitored. Based on the safety and efficacy outcomes of those who participated in the trial, the request for the next more extensive Trial using adipose (fat) derived stem cells following a min-liposuction has been submitted to the FDA. You may follow the beginning of enrollment for the next Stromal Vascular Fraction (adipose derived stem cells as contrasted to those derived from bone marrow) by visiting www.PersonalizedStemCells.com or reading this weekly Blog.
Bone Marrow Derived Stem Cells
The use of Adult Mesenchymal Stem Cells (MSCs) recovered from your bone marrow via needle aspiration is still the basis of Cellular Orthopedics and Regenerative Medicine for symptomatic and function limiting osteoarthritis in the United States as well as ongoing, in our office. By visiting www.sheinkopmd.com you may stay informed as well as learn about advances in technique and the process including the advances in “boosters”.
Wharton’s Jelly
It is a unique substance found in the wall of the umbilical cord. Contained in Wharton’s jelly is type 1 collagen, a potential source of repair for structural defects in an arthritic joint. As of this present time, the product may only be used as an acellular application with FDA oversight in a clinical trial. To learn more about Clinical Trials of type 1 collagen for arthritic structural defects, call my office and schedule a consultation (312) 475-1893
The Platelets, Growth Factors, and Extra Cellular Vesicles (ECVs) Circulating in your Blood
By using your proteins and molecules obtained from you circulating blood, I am able to provide superior clinical outcomes when compared to hyaluronic acid; that is the gel or cushion so highly visible in the media. Commonly referred to as Platelet Rich Plasma (PRP), there is so much more to the generic term PRP today than when first applied ten years ago in an arthritic setting. The next leap forward in PRP and Extracellular Vesicles will take place on Wednesday when I perform a Bone Marrow Concentrate procedure as a means of introducing stem cells for a patient with an arthritic knee, not interested in a Total Knee Replacement. In addition to the recovery of Adult Mesenchymal Stem cells, Growth factors, Precursor Cells, and Platelets; the Extracellular Vesicles containing messenger RNA will be recovered from the patient’s bone marrow, concentrated and injected into the arthritic knee.
To learn more or schedule a consultation, call (312) 475-1893. My website may be visited at www.sheinkopmd.com.